돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 381707생성일: 2026년 10월 26일

Methyl iodide → Simvastatin butylamide

https://huagongshe.com/reaction/381707

반응식

참여 물질

역할이름HCID투입량
반응물Methyl iodideHCID 6328—
반응물Lovastatin butylamideHCID 86584093—
생성물Simvastatin butylamideHCID 86584094—

반응 단계

In U.S. Pat. No. 4,820,850 (89)/CA 1,287,063 (91, Merck), lovastatin is reacted with butylamine to produce lovastatin butylarnide. The two hydroxy groups in the butylamide are protected with tert-butyldimethylsilyl chloride to produce a disilylated lovastatin butylamide. The disilylated lovastatin butylamide is enolized with lithium pyrrolidide and the enolate is alkylated with methyl iodide to produce a disilylated simvastatin butylamide on aqueous workup. The silyl protecting groups are removed using hydrofluoric acid to produce simvastatin butylamide. The simvastatin butylamide is hydrolyzed using sodium hydroxide and, following acidification, the dihydroxy acid form of simvastatin is obtained. The dihydroxy acid compound is reacted with ammonium hydroxide to produce an ammonium salt which is then relactonized by heating to produce simvastatin.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06307066B1
출처 데이터셋uspto-grants-2001_10
ORD IDord-063b2fcd66384cdb8f10e99eba287446
출처 메모uspto-grants-2001_10